or Try an Advanced Search...

    Technical Analysis for CLSD - Clearside Biomedical, Inc.

    Grade Last Price % Change Price Change
    D 1.31 3.97% 0.05
    CLSD closed down 5.97 percent on Thursday, April 25, 2024, on 31 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Up
    Historical CLSD trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 3.97%
    NR7 Range Contraction 3.97%
    Down 3 Days in a Row Weakness 3.97%
    20 DMA Resistance Bearish -2.24%
    50 DMA Resistance Bearish -2.24%
    Wide Bands Range Expansion -2.24%
    Gapped Up Strength -2.24%
    50 DMA Resistance Bearish -4.38%
    Fell Below 20 DMA Bearish -4.38%
    Wide Bands Range Expansion -4.38%
    Older End-of-Day Signals for CLSD ...

       Recent Intraday Alerts

    Alert Time
    Rose Above 20 DMA about 3 hours ago
    60 Minute Opening Range Breakout about 3 hours ago
    Rose Above Previous Day's High about 3 hours ago
    Rose Above 10 DMA about 3 hours ago
    20 DMA Resistance about 5 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    CLSD Chart by TradingView
    Basic chart:

    Profile

    Clearside BioMedical, Inc., a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biopharmaceutical Eye Ophthalmology Macular Degeneration Macular Edema Retina Veins Wet Age Related Macular Degeneration Drug Therapies Uveitis Adverum Biotechnologies Non Infectious Uveitis Retinal Vein Occlusion

    Is CLSD a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 16 Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of Directors
    Apr 2 Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference
    Mar 18 Clearside Biomedical appoints Chong as CMO
    Mar 18 Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
    Mar 14 Clearside Biomedical Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
    Mar 13 Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript
    Mar 13 Q4 2023 Clearside Biomedical Inc Earnings Call
    Mar 13 Clearside Biomedical, Inc. (CLSD) Q4 2023 Earnings Call Transcript
    Mar 12 Clearside Biomedical Inc (CLSD) Reports Significant Licensing Revenue Growth in Q4 and Full ...
    Mar 12 Clearside Biomedical GAAP EPS of -$0.08 beats by $0.01, revenue of $6.35M beats by $2.11M
    See more CLSD news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.12
    52 Week Low 0.6501
    Average Volume 433,537
    200-Day Moving Average 1.15
    50-Day Moving Average 1.45
    20-Day Moving Average 1.33
    10-Day Moving Average 1.30
    Average True Range 0.15
    RSI (14) 42.86
    ADX 26.85
    +DI 12.08
    -DI 18.22
    Chandelier Exit (Long, 3 ATRs) 1.31
    Chandelier Exit (Short, 3 ATRs) 1.55
    Upper Bollinger Bands 1.53
    Lower Bollinger Band 1.14
    Percent B (%b) 0.31
    BandWidth 29.19
    MACD Line -0.05
    MACD Signal Line -0.06
    MACD Histogram 0.0058
    Fundamentals Value
    Market Cap 80.15 Million
    Num Shares 63.6 Million
    EPS -0.61
    Price-to-Earnings (P/E) Ratio -2.07
    Price-to-Sales 40.85
    Price-to-Book 3.93
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.38
    Resistance 3 (R3) 1.39 1.37 1.36
    Resistance 2 (R2) 1.37 1.34 1.36 1.35
    Resistance 1 (R1) 1.31 1.32 1.30 1.30 1.35
    Pivot Point 1.29 1.29 1.28 1.28 1.29
    Support 1 (S1) 1.23 1.26 1.22 1.22 1.17
    Support 2 (S2) 1.21 1.24 1.20 1.17
    Support 3 (S3) 1.15 1.21 1.16
    Support 4 (S4) 1.14